Literature DB >> 10379022

Molecular basis of the neurodegenerative disorders.

J B Martin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10379022     DOI： 10.1056/NEJM199906243402507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  93 in total

1.  Solubilization and disaggregation of polyglutamine peptides.

Authors:  S Chen; R Wetzel
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 3.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 4.  Genetics 101: detecting mutations in human genes.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

5.  FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Authors:  Tomomi Kiyota; Kaitlin L Ingraham; Michael T Jacobsen; Huangui Xiong; Tsuneya Ikezu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

6.  Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

7.  Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Authors:  Maria G Matera; Daniele Sancarlo; Francesco Panza; Carolina Gravina; Grazia D'Onofrio; Vincenza Frisardi; Grazia Longo; Luigi P D'Ambrosio; Filomena Addante; Massimiliano Copetti; Vincenzo Solfrizzi; Davide Seripa; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-04-20

Review 8.  Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.

Authors:  Michael W Jann; Kara L Shirley; Gary W Small
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy.

Authors:  Lauren E Buchanan; Joshua K Carr; Aaron M Fluitt; Andrew J Hoganson; Sean D Moran; Juan J de Pablo; James L Skinner; Martin T Zanni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 10.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.